ADVANCED SOLID TUMOR MALIGNANCIES
Clinical trials for ADVANCED SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug JSKN016HC enters first human tests for advanced cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called JSKN016HC in about 42 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants must be in fairly …
Matched conditions: ADVANCED SOLID TUMOR MALIGNANCIES
Phase: PHASE1 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New blood test aims to predict who will respond to immunotherapy
Knowledge-focused Not yet recruitingThis study will test a new automated blood test that measures how well a patient's T-cells (immune cells) are working. The goal is to see if the test results match how well the cancer responds to standard immunotherapy drugs like anti-PD1 or anti-CTLA4. The study will include 100…
Matched conditions: ADVANCED SOLID TUMOR MALIGNANCIES
Phase: NA • Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:54 UTC